Page last updated: 2024-08-16

propranolol and cyclosporine

propranolol has been researched along with cyclosporine in 43 studies

Research

Studies (43)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (16.28)	18.2507
2000's	15 (34.88)	29.6817
2010's	18 (41.86)	24.3611
2020's	3 (6.98)	2.80

Authors

Authors	Studies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Cvetkovic, M; Kim, RB; Leake, B; Nadeau, J; Roden, MM; Walubo, A; Wilkinson, GR	1
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA	1
Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M	1
Attwood, D; D'Emanuele, A; Jevprasesphant, R; Penny, J	1
Lombardo, F; Obach, RS; Waters, NJ	1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Avdeef, A; Tam, KY	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bockus, AT; Gardner, JW; Glassey, E; Hewitt, WM; Hund, KC; Jacobson, MP; Kalgutkar, AS; Lexa, KW; Liras, S; Lokey, RS; Mathiowetz, AM; Price, DA; Pye, CR; Schwochert, JA	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Bae, MA; Choi, J; Choi, JH; Kim, MJ; Kim, YC; Lee, D; Lee, KR; Lee, S; Park, CJ; Seo, J; Shin, DS; Song, YK	1
Goldberg, J; Gryn, J; Viner, E	1
Patterson, FK; Wigler, PW	1
Goos, M; Mertins, K; Nussbaum, G; Ockenfels, HM; Schultewolter, T; Wagner, SN	1
Araki, W; Lee, RK; Wurtman, RJ	1
Ku, YS; Lee, YH	2
Landwojtowicz, E; Seelig, A	1
Martín-Comín, J; Nascimento Cardoso, V; Roca, M	1
Afify, EA; El-Mas, MM; Omar, AG; Sharabi, FM	1
Al-Sabah, A; Lazarus, JH; Obuobie, K	1
Bennett, T; Fallgren, B; Gardiner, SM; Kemp, PA; March, JE	1
Bansal, T; Kaul, CL; Panchagnula, R; Varma, MV	1
El-Mas, MM; Omar, AG	1
Inamdar, MN; Kumar, NP; Venkataraman, BV	1
Alavian, KN; Bonanni, L; Demady, DR; Demarco, U; Dworetzky, SI; Gribkoff, VK; Jonas, EA; Lazrove, E; Li, H; Mangold, JE; Mariggio, MA; Nabili, P; Onofrj, M; Sacchetti, S; Signore, AP; Smith, PJ; Thomas, A; Zhang, P	1
Chen, B; Cui, H; Lv, Z; Shao, C; Xie, G; Yao, Z; Yuan, W	1

Reviews

1 review(s) available for propranolol and cyclosporine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

42 other study(ies) available for propranolol and cyclosporine

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:3 Topics: Bile Acids and Salts; Biological Transport, Active; Carrier Proteins; Cells, Cultured; HeLa Cells; Humans; Kinetics; Liver; Nicotine; Organic Anion Transporters, Sodium-Dependent; Plasmids; RNA, Messenger; Salicylates; Symporters; Vaccinia virus; Valproic Acid	1999
Rational use of in vitro P-glycoprotein assays in drug discovery. The Journal of pharmacology and experimental therapeutics, 2001, Volume: 299, Issue:2 Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera	2001
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies. Biochemical and biophysical research communications, 2004, Mar-19, Volume: 315, Issue:4 Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity	2004
The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability. Journal of controlled release : official journal of the Controlled Release Society, 2004, Mar-24, Volume: 95, Issue:3 Topics: Acetates; Administration, Oral; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Caco-2 Cells; Cell Survival; Colchicine; Cyclosporine; Drug Carriers; Endocytosis; Epithelium; Humans; Laurates; Polyamines; Prodrugs; Propranolol; Solubility; Temperature	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship	2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability? Journal of medicinal chemistry, 2010, May-13, Volume: 53, Issue:9 Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
QSAR-based permeability model for drug-like compounds. Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8 Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors	2012
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment. Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10 Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers	2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Probing the Physicochemical Boundaries of Cell Permeability and Oral Bioavailability in Lipophilic Macrocycles Inspired by Natural Products. Journal of medicinal chemistry, 2015, Jun-11, Volume: 58, Issue:11 Topics: Administration, Oral; Animals; Biological Availability; Biological Products; Cell Membrane Permeability; Chemical Phenomena; Hydrogen Bonding; Macrocyclic Compounds; Magnetic Resonance Spectroscopy; Male; Microsomes, Liver; Models, Molecular; Molecular Structure; Peptides, Cyclic; Rats; Rats, Wistar; Solvents; Structure-Activity Relationship	2015
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
Interplay among Conformation, Intramolecular Hydrogen Bonds, and Chameleonicity in the Membrane Permeability and Cyclophilin A Binding of Macrocyclic Peptide Cyclosporin O Derivatives. Journal of medicinal chemistry, 2021, 06-24, Volume: 64, Issue:12 Topics: Animals; Caco-2 Cells; Cell Membrane Permeability; Cyclization; Cyclophilin A; Cyclosporine; Cyclosporins; Drug Design; Humans; Hydrogen Bonding; Male; Mice, Inbred ICR; Molecular Conformation; Protein Binding	2021
Propranolol for the treatment of cyclosporine-induced headaches. Bone marrow transplantation, 1992, Volume: 9, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Headache; Humans; Male; Middle Aged; Propranolol	1992
Reversal agent inhibition of the multidrug resistance pump in human leukemic lymphoblasts. Biochimica et biophysica acta, 1994, Jan-03, Volume: 1189, Issue:1 Topics: Amiodarone; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cyclosporine; Drug Resistance; Humans; Leukemia; Membrane Glycoproteins; Propranolol; Propylamines; Quinidine; Quinine; Rhodamine 123; Rhodamines; Stereoisomerism; Tumor Cells, Cultured	1994
Tyrosine phosphorylation in psoriatic T cells is modulated by drugs that induce or improve psoriasis. Dermatology (Basel, Switzerland), 1995, Volume: 191, Issue:3 Topics: Adolescent; Adult; Aged; Case-Control Studies; Cells, Cultured; Chloroquine; Cyclosporine; Ethanol; Female; Humans; Immunosuppressive Agents; Irritants; Lithium; Lymphocyte Activation; Male; Middle Aged; Phosphorylation; Phytohemagglutinins; Propranolol; Protein-Tyrosine Kinases; Psoriasis; T-Lymphocytes; Tacrolimus; Time Factors; Tyrosine	1995
Stimulation of amyloid precursor protein synthesis by adrenergic receptors coupled to cAMP formation. Proceedings of the National Academy of Sciences of the United States of America, 1997, May-13, Volume: 94, Issue:10 Topics: 8-Bromo Cyclic Adenosine Monophosphate; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Animals, Newborn; Astrocytes; Cells, Cultured; Cerebral Cortex; Colforsin; Cyclic AMP; Cyclosporine; Isoproterenol; Kinetics; Norepinephrine; Phosphatidylinositols; Propranolol; Rats; Receptors, Adrenergic, beta; RNA, Messenger; Signal Transduction; Transcription, Genetic	1997
Effects of propranolol on the pharmacokinetics of cyclosporine after intravenous and oral administration to control rats and rats with uranyl nitrate-induced acute renal failure. Research communications in molecular pathology and pharmacology, 1998, Volume: 102, Issue:3 Topics: Acute Kidney Injury; Administration, Oral; Adrenergic beta-Antagonists; Animals; Biliary Tract; Blood Urea Nitrogen; Cyclosporine; Dose-Response Relationship, Drug; Immunosuppressive Agents; Injections, Intravenous; Male; Propranolol; Rats; Rats, Sprague-Dawley; Uranyl Nitrate	1998
Effects of cyclosporin on the pharmacokinetics of propranolol after intravenous and oral administration to control rats and to rats with uranyl nitrate-induced acute renal failure. The Journal of pharmacy and pharmacology, 1999, Volume: 51, Issue:10 Topics: Acute Kidney Injury; Administration, Oral; Adrenergic beta-Antagonists; Animals; Cyclosporine; Immunosuppressive Agents; Injections, Intravenous; Male; Propranolol; Rats; Rats, Sprague-Dawley; Uranyl Nitrate	1999
Structure-activity relationship of P-glycoprotein substrates and modifiers. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2000, Volume: 12, Issue:1 Topics: Adenosine Triphosphatases; Amiodarone; Amitriptyline; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; CHO Cells; Colchicine; Cricetinae; Cyclosporine; Daunorubicin; Diltiazem; Kinetics; Micelles; Progesterone; Propranolol; Structure-Activity Relationship; Verapamil; Vinblastine	2000
[No influence of propanolol, cyclosporine, adriamycin, and nifedipine on the in vitro labelling of erythrocytes]. Revista espanola de medicina nuclear, 2002, Volume: 21, Issue:1 Topics: Adult; Centrifugation; Cyclosporine; Doxorubicin; Edetic Acid; Erythrocytes; Humans; Hypochlorous Acid; Isotope Labeling; Nifedipine; Propranolol; Radiopharmaceuticals; Technetium; Tin Compounds	2002
Cyclosporine adversely affects baroreflexes via inhibition of testosterone modulation of cardiac vagal control. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 301, Issue:1 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Atropine; Baroreflex; Blood Pressure; Cyclosporine; Heart; Heart Rate; Immunosuppressive Agents; Male; Muscarinic Antagonists; Orchiectomy; Phenylephrine; Propranolol; Rats; Rats, Wistar; Testosterone; Vagus Nerve	2002
Subacute thyroiditis in an immunosuppressed patient. Journal of endocrinological investigation, 2002, Volume: 25, Issue:2 Topics: Adult; Autoimmunity; Bone Marrow Transplantation; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lithium; Male; Prednisolone; Propranolol; Thyroiditis, Subacute; Thyrotropin; Thyroxine	2002
Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats. British journal of pharmacology, 2004, Volume: 141, Issue:4 Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Cyclosporine; Drug Interactions; Heart Rate; Hemodynamics; Immunosuppressive Agents; Indans; Infusions, Intravenous; Losartan; Male; Phentolamine; Propranolol; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Renal Circulation; Sirolimus; Tacrolimus	2004
Reversed-phase liquid chromatography with ultraviolet detection for simultaneous quantitation of indinavir and propranolol from ex-vivo rat intestinal permeability studies. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004, Jul-05, Volume: 806, Issue:2 Topics: Adrenergic beta-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Chromatography, High Pressure Liquid; Cyclosporine; HIV Protease Inhibitors; Indinavir; Intestinal Absorption; Male; Propranolol; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet	2004
Time-domain evaluation of cyclosporine interaction with hemodynamic variability in rats. Cardiovascular drugs and therapy, 2004, Volume: 18, Issue:6 Topics: Animals; Atropine; Blood Pressure; Cyclosporine; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Interactions; Heart Rate; Hemodynamics; Male; Propranolol; Rats; Rats, Wistar; Time Factors	2004
Comparative interaction of few antihypertensive drugs with cyclosporine-A in rats. Indian journal of experimental biology, 2007, Volume: 45, Issue:7 Topics: Acetylcholine; Animals; Antihypertensive Agents; Aorta, Thoracic; Chromatography, High Pressure Liquid; Cyclosporine; Diltiazem; Drug Interactions; Enalapril; Losartan; Male; Olive Oil; Plant Oils; Propranolol; Rats; Rats, Wistar	2007
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency. Brain research, 2012, Mar-29, Volume: 1446 Topics: Adenosine Triphosphate; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Biophysical Phenomena; Brain; Cell Survival; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Energy Metabolism; Enzyme Inhibitors; Humans; Male; Membrane Potential, Mitochondrial; Mice; Mitochondria; Mitochondrial Membranes; Neuroblastoma; Neurons; Oligopeptides; Oxygen Consumption; Patch-Clamp Techniques; Propranolol; Rats; Rats, Sprague-Dawley	2012
Cyclosporin-A reduced the cytotoxicity of propranolol in HUVECs via p38 MAPK signaling. Medicine, 2022, Jan-28, Volume: 101, Issue:4 Topics: Antioxidants; Apoptosis; Cell Proliferation; Cyclosporine; Hemangioma; Human Umbilical Vein Endothelial Cells; Humans; p38 Mitogen-Activated Protein Kinases; Propranolol; Reactive Oxygen Species	2022